Status:
NOT_YET_RECRUITING
SuprAglottic Jet Ventilation vs High-flow Nasal Oxygen in Tubeless Laryngotracheal Surgery
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Airway Managment
Laryngotracheal Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to investigate two oxygenation methods (high flow nasal oxygen and supraglottic, superimposed high-frequency jet ventilation) for tubeless laryngotracheal surgeries concerning their sa...
Detailed Description
Eligible adult patients will be prepared for intubation according to the local SOPs of the anesthesia departments. Mandatory monitoring will consist of: SpO2, HR, NIBP, tcCO2, EEG, TOF and EIT. Induc...
Eligibility Criteria
Inclusion
- Written informed consent
- Patients aged ≥18 years
- Patients requiring elective tubeless laryngotracheal surgery
Exclusion
- Patients \<18 years
- High risk of aspiration which concludes the consideration of using a tube in order to prevent aspiration.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06609915
Start Date
June 1 2025
End Date
April 1 2027
Last Update
March 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital
Bern, Switzerland, 3010
2
University Hospital Bern
Bern, Switzerland, 3010